These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11095555)

  • 1. Prothrombin gene mutation uncommon in pulmonary embolism.
    Kohlmeier RE; Cho CG; Bux RC; Guerra L; Rulon JJ; Selby DM; Gulley ML
    South Med J; 2000 Nov; 93(11):1073-7. PubMed ID: 11095555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
    Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
    Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
    [No Abstract]   [Full Text] [Related]  

  • 6. Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.
    Lenicek Krleza J; Jakovljevic G; Bronic A; Coen Herak D; Bonevski A; Stepan-Giljevic J; Roic G
    Pathophysiol Haemost Thromb; 2010; 37(1):24-9. PubMed ID: 20664190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C resistance is uncommon in sudden death due to pulmonary embolism.
    Rulon JJ; Cho CG; Guerra LL; Bux RC; Gulley ML
    J Forensic Sci; 1999 Nov; 44(6):1111-3. PubMed ID: 10582351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
    Glueck CJ; Wang P
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey.
    Ayyildiz O; Kalkanli S; Batun S; Aybak M; Isikdogan A; Tiftik N; Bolaman Z; Soker M; Muftuoglu E
    Heart Vessels; 2004 Jul; 19(4):164-6. PubMed ID: 15278388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.